Fri | Jun 5, 2026

Country races to vaccinate elderly, but many are reluctant

Published:Tuesday | December 27, 2022 | 12:52 AM
A nurse prepares a shot of COVID-19 vaccine at a community health centre in Nantong in eastern China’s Jiangsu province on December 9.
A nurse prepares a shot of COVID-19 vaccine at a community health centre in Nantong in eastern China’s Jiangsu province on December 9.

BEIJING (AP):

Chinese authorities are going door to door and paying people older than 60 to get vaccinated against COVID-19. But even as cases surge, 64-year-old Li Liansheng said his friends are alarmed by stories of fevers, blood clots, and other side effects.

“When people hear about such incidents, they may not be willing to take the vaccines,” said Li, who had been vaccinated before he caught COVID-19. A few days after his 10-day bout with the virus, Li is nursing a sore throat and cough. He said it was like a “normal cold” with a mild fever.

China has joined other countries in treating cases instead of trying to stamp out virus transmission by dropping or easing rules on testing, quarantines, and movement as it tries to reverse an economic slump. But the shift has flooded hospitals with feverish, wheezing patients.

The National Health Commission announced a campaign on November 29 to raise the vaccination rate among older Chinese, which health experts say is crucial to avoiding a healthcare crisis. It is also the biggest hurdle before the ruling Communist Party can lift the last of the world’s most stringent antivirus restrictions.

China kept case numbers low for two years with a “zero-COVID” strategy that isolated cities and confined millions of people to their homes. Now, as it backs off that approach, it is facing the widespread outbreaks that other countries have already gone through.

The health commission has recorded only six COVID-19 fatalities this month, bringing the country’s official toll to 5,241. That is despite multiple reports by families of relatives dying.

China only counts deaths from pneumonia or respiratory failure in its official COVID-19 toll, a health official said last week. That unusually narrow definition excludes many deaths other countries would attribute to COVID-19.

Experts have forecast 1 to 2 million deaths in China through the end of 2023.

Li, who was exercising at the leafy grounds of central Beijing’s Temple of Heaven, said he is considering getting a second booster due to the publicity campaign: “As long as we know the vaccine won’t cause big side effects, we should take it.”

Neighbourhood committees that form the lowest level of government have been ordered to find everyone 65 and older and keep track of their health. They are doing what state media call the “ideological work” of lobbying residents to persuade elderly relatives to get vaccinated.

In Beijing, the Chinese capital, the Liulidun neighbourhood is promising people over 60 up to 500 yuan (US$70) to get a two-dose vaccination course and one booster.

The National Health Commission announced on December 23 that the number of people being vaccinated daily had more than doubled to 3.5 million nationwide. But that still is a small fraction of the tens of millions of shots that were being administered every day in early 2021.

Older people are put off by potential side effects of Chinese-made vaccines, for which the government hasn’t announced results of testing on people in their 60s and older.

Li said a 55-year-old friend suffered fevers and blood clots after being vaccinated. He said they can’t be sure the shot was to blame, but his friend is reluctant to get another.

“It’s also said the virus keeps mutating,” Li said. “How do we know if the vaccines we take are useful?”

Some are reluctant because they have diabetes, heart problems, and other health complications despite warnings from experts that it is even more urgent for them to be vaccinated because the risks of COVID-19 are more serious than potential vaccine side effects in almost everyone.